» Articles » PMID: 30446963

Detecting Optic Nerve Lesions in Clinically Isolated Syndrome and Multiple Sclerosis: Double-inversion Recovery Magnetic Resonance Imaging in Comparison with Visually Evoked Potentials

Overview
Journal J Neurol
Specialty Neurology
Date 2018 Nov 18
PMID 30446963
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aim: Optic neuritis (ON) is a frequent manifestation of multiple sclerosis (MS), traditionally diagnosed clinically and by visually evoked potentials (VEP). However, ON can also be assessed by MRI. Here we compare the diagnostic performance of 3D-double inversion recovery-MRI (3D-DIR) and VEPs in patients with definite MS or clinically isolated syndrome (CIS).

Methods: 39 patients and 17 healthy controls were studied. Whole-brain-3D-DIR images (3T) were independently assessed for DIR-hyperintense optic nerve lesions (DHLs) by two neuroradiologists, and results related to quantitative VEP-parameters.

Results: Interrater concordance for DHLs was high (κ = 0.82). No DHLs were observed in controls. In patients, abnormal VEPs, i.e. prolonged latencies, diminished amplitudes or abnormal latency or amplitude differences (re contralateral nerve) of the P100-component, were observed in 22, and DHLs in 32 of 78 optic nerves, the latter including 11 nerves with normal VEPs, 10 without clinical signs or history of ON, and 6 with both normal VEPs and no clinical evidence for ON. Using either abnormal VEPs and/or presence of DHLs and/or clinical evidence for ON as a compound reference criterion of optic nerve affection, sensitivity was significantly higher for 3D-DIR than for VEPs (91%, 95%-CI 77-98% vs. 63%, 95%-CI 45-79%, respectively, p = 0.006).

Conclusion: DHLs are highly specific for optic nerve pathology. In the context of MS, 3D-DIR-MRI is a suitable tool to reveal acute or chronic optic nerve lesions and more sensitive than VEPs. The significance of optic nerve involvement in the diagnostic classification of CIS vs. definite MS requires further study.

Citing Articles

Research progress of optic nerve imaging during 1991-2023: a bibliometric analysis.

Zhang H, Lee X, Tan K, Zhang Q, Li J, Zhou H Quant Imaging Med Surg. 2024; 14(9):6566-6578.

PMID: 39281143 PMC: 11400669. DOI: 10.21037/qims-24-870.


The influence of MOGAD on diagnosis of multiple sclerosis using MRI.

Geraldes R, Arrambide G, Banwell B, Rovira A, Cortese R, Lassmann H Nat Rev Neurol. 2024; 20(10):620-635.

PMID: 39227463 DOI: 10.1038/s41582-024-01005-2.


Improving criteria for dissemination in space in multiple sclerosis by including additional regions.

Foster M, Pontillo G, Davagnanam I, Collorone S, Prados F, Kanber B Ann Clin Transl Neurol. 2024; 11(10):2572-2582.

PMID: 39078773 PMC: 11514922. DOI: 10.1002/acn3.52170.


Value of Optic Nerve MRI in Multiple Sclerosis Clinical Management: A MAGNIMS Position Paper and Future Perspectives.

Sastre-Garriga J, Vidal-Jordana A, Toosy A, Enzinger C, Granziera C, Frederiksen J Neurology. 2024; 103(3):e209677.

PMID: 39018513 PMC: 11271394. DOI: 10.1212/WNL.0000000000209677.


Macular OCT's Proficiency in Identifying Retrochiasmal Visual Pathway Lesions in Multiple Sclerosis-A Pilot Study.

Cujba L, Banc A, Stan C, Drugan T, Nicula C Diagnostics (Basel). 2024; 14(12).

PMID: 38928637 PMC: 11202879. DOI: 10.3390/diagnostics14121221.


References
1.
Hadhoum N, Hodel J, Defoort-Dhellemmes S, Duhamel A, Drumez E, Zephir H . Length of optic nerve double inversion recovery hypersignal is associated with retinal axonal loss. Mult Scler. 2015; 22(5):649-58. DOI: 10.1177/1352458515598021. View

2.
Wattjes M, Lutterbey G, Gieseke J, Traber F, Klotz L, Schmidt S . Double inversion recovery brain imaging at 3T: diagnostic value in the detection of multiple sclerosis lesions. AJNR Am J Neuroradiol. 2007; 28(1):54-9. PMC: 8134107. View

3.
Tartaglione A, Oneto A, Bandini F, Spadavecchia L, Gandolfo E, Favale E . Electrophysiological detection of "silent" plaques in the optic pathways. Acta Neurol Scand. 1987; 76(4):246-50. DOI: 10.1111/j.1600-0404.1987.tb03575.x. View

4.
Filippi M, Preziosa P, Meani A, Ciccarelli O, Mesaros S, Rovira A . Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study. Lancet Neurol. 2017; 17(2):133-142. DOI: 10.1016/S1474-4422(17)30469-6. View

5.
Thompson A, Banwell B, Barkhof F, Carroll W, Coetzee T, Comi G . Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2017; 17(2):162-173. DOI: 10.1016/S1474-4422(17)30470-2. View